| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $9.82 ▲ +1.41% | Yesterday | $9.62 ▼ -0.59% | Tomorrow's Immix Biopharma Inc. Common Stock (IMMX) setup is anchored to $9.68 and targets $9.82 (+1.41%). The near-term read is upside; watch $9.97 / $9.39 because daily realized volatility is about 7.29%. |
Tomorrow's Immix Biopharma Inc. Common Stock (IMMX) setup is anchored to $9.68 and targets $9.82 (+1.41%). The near-term read is upside; watch $9.97 / $9.39 because daily realized volatility is about 7.29%. | ||||
| Week | $10.11 ▲ +4.40% | Last Week | $9.50 ▼ -1.85% | The 7-day Immix Biopharma Inc. Common Stock model moves from $9.50 to $10.11 (+4.40%). It gives upside momentum context for this stock, so breaks around $9.97 / $9.39 matter more than a single tick. |
The 7-day Immix Biopharma Inc. Common Stock model moves from $9.50 to $10.11 (+4.40%). It gives upside momentum context for this stock, so breaks around $9.97 / $9.39 matter more than a single tick. | ||||
| Month | $10.59 ▲ +9.37% | Last Month | $9.30 ▼ -3.94% | The 1-month Immix Biopharma Inc. Common Stock target is $10.59 (+9.37%), compared with the live reference near $9.68. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Immix Biopharma Inc. Common Stock target is $10.59 (+9.37%), compared with the live reference near $9.68. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $11.31 ▲ +16.82% | Last Year | $9.00 ▼ -7.07% | The 1-year Immix Biopharma Inc. Common Stock scenario points to $11.31 (+16.82%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Immix Biopharma Inc. Common Stock scenario points to $11.31 (+16.82%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $13.00 ▲ +34.29% | 5 Years Ago | $8.29 ▼ -14.40% | The 5-year Immix Biopharma Inc. Common Stock view is $13.00 (+34.29%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Immix Biopharma Inc. Common Stock view is $13.00 (+34.29%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| Price | $9.68 | Mid |
| Daily Change | -4.06% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 66% | Above |
| Data Source | nasdaq-screener | Mid |
| Current | $9.68 | Daily Change | -4.06% |
| Market Cap | $513.16M | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.